PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
20-Jan-2025 Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® Formycon AG
15-Jan-2025 Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025 Drägerwerk AG & Co. KGaA
15-Jan-2025 Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System Vetter
15-Jan-2025 Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE® (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland Santhera
15-Jan-2025 Legalization of cannabis brings strong growth: Cantourage Group SE increases its sales by 118% to EUR 51.4 million in full year 2024 Cantourage Group SE
15-Jan-2025 Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects BRAIN Biotech AG
15-Jan-2025 Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Formycon AG
14-Jan-2025 Vetter introduces the next evolution of the V-OVS® syringe closure system Vetter
14-Jan-2025 Er-Kim Announces Exclusive Distribution Agreement with the MEDICE Health Family For Vafseo® in Central & Eastern Europe Er-Kim
14-Jan-2025 Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE
14-Jan-2025 Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers Terumo Blood and Cell Technologies
14-Jan-2025 Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0 Pharmapack
14-Jan-2025 Elsevier appoints Stuart Whayman as President of Corporate Markets Elsevier
14-Jan-2025 Domino’s New Mx-Series Electric Range Provides a Smarter, Safer, and More Sustainable Solution for Pallet Labelling Domino Printing Sciences (Domino)
14-Jan-2025 Nxera Pharma Provides Update on Neurocrine’s Progress with its Partnered Muscarinic Agonist Portfolio Nxera Pharma
14-Jan-2025 HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC HUTCHMED
14-Jan-2025 Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program Lilly
14-Jan-2025 AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma AbbVie
13-Jan-2025 OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe OncoZenge AB
13-Jan-2025 Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A Rappta Therapeutics